Andrea Belschner, Ccrp
About Andrea Belschner, Ccrp
Andrea Belschner serves as the Vice President of Worldwide Clinical Operations & Site Strategy at Inozyme Pharma, bringing extensive experience in clinical operations from her previous roles at X4 Pharmaceuticals and various healthcare institutions.
Current Role at Inozyme Pharma
Andrea Belschner currently serves as the Vice President of Worldwide Clinical Operations & Site Strategy at Inozyme Pharma. She has held this position since 2023, working from the company's Boston, Massachusetts office. In her role, she focuses on overseeing clinical operations and developing strategies for site selection and management in clinical trials.
Previous Experience at X4 Pharmaceuticals
Prior to her current role, Andrea Belschner worked at X4 Pharmaceuticals in various capacities. She served as Vice President of Clinical Operations from 2022 to 2023, and as Senior Director of Clinical Operations from 2021 to 2022. Additionally, she held the position of Director of Clinical Operations for Rare Diseases from 2020 to 2021. Her tenure at X4 Pharmaceuticals contributed to her extensive experience in clinical operations.
Background in Clinical Operations
Andrea Belschner has a robust background in clinical operations, having worked in various roles across multiple organizations. She was an Associate Director of Clinical Operations at Tepha, Inc. in 2019, and has held several positions at Beth Israel Deaconess Medical Center, including Clinical Trials Specialist and Clinical Research Coordinator. Her experience spans over two decades in the clinical research field.
Educational Background
Andrea Belschner studied at Bay State College from 1994 to 1995 and later attended Emmanuel College in Boston from 1998 to 2000. Her educational background provides a foundation for her extensive career in clinical operations and research.
Expertise in Regulatory Compliance
Andrea Belschner has a demonstrated history of working with the U.S. Food and Drug Administration (FDA), indicating her expertise in regulatory compliance and submissions. This experience is crucial for her roles in clinical operations, where adherence to regulatory standards is essential for the success of clinical trials.